hotspot -WSS

hotspot

author：explore 2025-09-30 20:34:34 - browse：92

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Apple Watch's A

hotspot

WSS

Study: People of West African ancestry at greater risk of cardiac amyloidosis

John Green on his newest strategy for fighting tuberculosis

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Study: Adult vaccinations pay for themselves in societal benefits

FDA advisers back CAR

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Wikipedia

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Hepatitis C has a cure — but many Americans still lack access to it

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Dobbs anniversary: the lost opportunity of abortion as health care

Amid AI frenzy, a top HHS official's quest to create safeguards

Hepatitis C has a cure — but many Americans still lack access to it

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: CAR

hotspot

First U.S. drug developed to treat liver disease MASH is approved

RaDonda Vaught links Vanderbilt hospital issues to patient death

Why depression after traumatic brain injury is distinct

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

EPA limits use of carcinogenic gas for sterilizing medical devices

FDA advisers back CAR

hotspot

hotspot

Wikipedia

Wikipedia